세계의 체외 독성 검사 시장 : 제품 및 서비스, 독성 엔드포인트 및 시험, 기술, 방법론, 산업별 - 예측(-2028년)

In Vitro Toxicology Testing Market by Product & Service (Assays (ELISA & Western Blot), Equipment, Consumable, Software), Toxicity Endpoints (ADME, Genotoxicity, Cytotoxicity), Technology, Method, Industry (Pharma, Cosmetics) - Global Forecast to 2028

US $ 4,950 ￦ 6,827,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,171,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,240,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,792,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

조사 범위
조사 대상년도	2021년-2028년
기준년도	2022년
예측 기간	2023년-2028년
검토 단위	10억 달러
부문	제품 및 서비스별, 기술별, 독성 엔드포인트 및 시험별, 산업별, 방법론별
대상지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동/아프리카

체외 독성 검사 시장은 2023년 108억 달러에서 2028년 171억 달러에 달할 것으로 예상되며, 예측 기간 동안 9.5%의 CAGR을 나타낼 것으로 예상됩니다.

독성학 기기의 기술 발전, 조기 독성 검출을 위한 연구개발, in vitro 독성학 검사법을 이용한 신약 개발 및 개인 맞춤형 의료에 대한 관심 증가, 예측 독성학에 대한 관심 증가가 이 시장의 성장에 기여한 것으로 보입니다.

2022년 세계 체외 독성 검사 시장에서 소모품 부문은 제품 및 서비스 부문에서 가장 큰 비중을 차지할 것으로 예상됩니다. 의약품, 식품, 화장품, 화학 등 산업 전반에 걸쳐 제품 안전성 향상에 대한 관심이 높아짐에 따라 체외 독성 검사 시장에서 소모품에 대한 수요가 증가하고 있습니다. 또한, 고품질 시약에 대한 수요 증가와 체외 독성 검사에서 배지 및 시약의 반복적인 사용도 이 시장의 성장을 가속하고 있습니다. 또한, 다양한 산업 분야에서 체외 독성 테스트의 도입이 증가함에 따라 소모품 시장 점유율이 확대될 것으로 예상됩니다.

유럽은 2022년 세계 체외 독성 검사 시장을 장악할 것으로 예상됩니다. 이러한 우위는 33개 이상의 과학 시설과 연구센터가 존재하고, 화장품 제조업체와 관련이 있는 경우가 많으며, 역동적이고 혁신적인 화장품 산업을 육성하고 있기 때문으로 분석됩니다. 또한, 이 지역에서는 생물학적 제제 및 첨단 제형에 대한 투자가 증가하고 있으며, 이는 다수의 블록버스터 의약품의 특허 만료가 임박한 것도 한 요인으로 작용하고 있습니다. 일반적으로 10-12년에 걸쳐 진행되는 의약품 개발 과정을 가속화해야 할 필요성이 높아지면서 체외 독성 검사에 대한 수요가 더욱 증가하고 있습니다. 특히 유럽연합(EU)은 규제 목적의 첨단 체외 독성 검사 프로토콜 개발 및 검증을 위한 연구를 지원하는 데 앞장서고 있습니다. 그 결과, 유럽 시장은 신약 및 퍼스널케어 제품 개발, 동물 실험을 대체할 수 있는 방법을 찾으려는 EU 회원국의 R&D 노력, 동물 실험을 거친 화장품 금지 등으로 인해 성장하고 있습니다.

이 보고서는 세계 체외 독성 검사(In Vitro Toxicity Testing) 시장을 조사했으며, 제품/서비스별, 독성 엔드포인트/시험별, 기술별, 방법론별, 산업별, 지역별 동향과 시장 진출기업 프로파일 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• 특허 분석
• 기술 분석
• 2023년-2024년 주요 컨퍼런스 및 이벤트
• 규제 상황
• Porter의 Five Forces 분석
• 주요 이해관계자와 구입 기준

제6장 체외 독성 검사 시장, 제품 및 서비스별

• 서론
• 소모품
• 어세이
• 서비스
• 장비
• 소프트웨어

제7장 체외 독성 검사 시장, 독성 엔드포인트 및 검사별

• 서론
• 흡수, 분포, 대사, 배설
• 유전 독성
• 피부 염증, 부식, 감작
• 세포 독성
• 눈독성
• 장기 독성
• 경피독성
• 광독성
• 기타

제8장 체외 독성 검사 시장, 업계별

• 서론
• 의약품 및 바이오의약품
• 소비자 케어
• 식품
• 기타

제9장 체외 독성 검사 시장, 기술별

• 서론
• 세포배양
• High Throughput Screening(HTS)
• TOXICOGENOMICS

제10장 체외 독성 검사 시장, 방법별

• 서론
• 세포 어세이
• 생화학 어세이
• 분자 독물학 어세이
• 체외 모델
• 인실리코 모델

제11장 체외 독성 검사 시장, 지역별

• 서론
• 유럽
• 북미
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제12장 경쟁 구도

• 개요
• 주요 시장 진출기업이 채택한 전략
• 매출 점유율 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 스타트업/중소기업 평가 매트릭스
• 경쟁 시나리오

제13장 기업 개요

• 주요 시장 진출기업
  • THERMO FISHER SCIENTIFIC INC.
  • AGILENT TECHNOLOGIES, INC.
  • MERCK KGAA
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • EUROFINS SCIENTIFIC
  • CHARLES RIVER LABORATORIES
  • SGS SA
  • REVVITY
  • BIO-RAD LABORATORIES, INC.
  • LONZA
  • EVOTEC SE
  • CATALENT, INC.
  • INTERTEK GROUP PLC
  • INOTIV
  • PROMEGA CORPORATION
• 기타 기업
  • BIOIVT
  • CREATIVE BIOLABS
  • SHANGHAI MEDICILON INC.
  • CREATIVE BIOARRAY
  • ARAGEN LIFE SCIENCES LTD.
  • ENZO BIOCHEM INC.
  • MICROBAC LABORATORIES, INC.
  • VIMTA LABS LTD.
  • PACIFIC BIOLABS, INC.
  • MB RESEARCH LABORATORIES

제14장 부록

LSH

영문 목차

영문목차

Report Description

Scope of the Report
Years Considered for the Study	2021-2028
Base Year	2022
Forecast Period	2023-2028
Units Considered	Value (USD) Billion
Segments	Product & Service, Technology, Toxicity Endpoint & Test, Industry, and Method
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

The in vitro toxicology testing market is projected to reach USD 17.1 billion by 2028 from an estimated USD 10.8 billion in 2023, at a CAGR of 9.5% during the forecast period. The growth of this market can be attributed to the technological advancements in toxicology equipment, research and development efforts aimed at early-stage toxicity detection, and growing focus on drug discovery and personalized medicine using in vitro toxicology testing methods and increasing focus on predictive toxicology.

"The consumables segment accounted for the largest share by product & services in 2022."

In 2022, the consumables segment accounted for the largest share of product & service in the global In vitro toxicology testing market. The factors like growing focus on improving product safety across industries, such as pharmaceutical, food, cosmetics, and chemicals, are driving the demand for consumables in the in vitro toxicology testing market. The increasing demand for high-quality reagents and the repeated use of media and reagents in vitro toxicology studies are also driving the growth of this market. Furthermore, the market share of the consumables market is expected to grow simultaneously with the increasing adoption of in vitro toxicology testing across various industries.

"The Europe has continued to dominate the in vitro toxicology testing market during the forecast period of 2023-2028."

The ban on animal testing in the region is the major factor driving the adoption of in vitro toxicology testing across all industries.

Europe dominated the global in vitro toxicology testing market in 2022. This dominance is attributed to the presence of over 33 scientific facilities and research centers, often associated with cosmetic manufacturers, fostering a dynamic and highly innovative cosmetics industry. Additionally, the region is experiencing increased investments in biologics and advanced dosage forms, partly driven by the impending patent expiration of numerous blockbuster drugs. The growing need to expedite the drug development process, which typically spans 10 to 12 years, has further fueled the demand for in vitro toxicology testing. Notably, the European Union has been at the forefront of supporting research for the development and validation of advanced in vitro toxicology testing protocols for regulatory purposes. Consequently, the European market is witnessing growth due to the development of novel drugs and personal care products, the research and development efforts of EU member states to find alternatives to animal testing, and the ban on cosmetics tested on animals.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• Eurofins Scientific (Luxembourg)
• Laboratory Corporation of America Holdings (US)
• Charles River Laboratories (US)
• SGS SA (Switzerland)
• Bio-Rad Laboratories, Inc. (US)
• Evotec SE (Germany)
• Promega Corporation (US)
• Catalent, Inc. (US)
• Agilent Technologies, Inc. (US)
• Intertek Group plc (UK)
• Revvity (US)
• Inotiv (US)
• BioIVT (US)
• Lonza (Switzerland)
• Creative Biolabs (US)
• Shanghai Medicilon Inc. (China)
• Creative Bioarray (US)
• Aragen Life Sciences Ltd. (India)
• Enzo Biochem Inc. (US)
• Microbac Laboratories, Inc. (US)
• Vimta Labs Ltd. (India)
• Pacific BioLabs Inc. (US)
• MB Research Laboratories (US)

Research Coverage:

This research report categorizes the In vitro toxicology testing market by product and service (consumables, assays, equipment, software, and services), toxicity endpoints & tests (absorption, distribution, metabolism, and excretion (ADME), skin irritation, corrosion, and sensitization, genotoxicity, cytotoxicity, ocular toxicity, organ toxicity, phototoxicity, dermal toxicity, and other toxicity endpoints & tests), industry (pharmaceutical & biopharmaceutical, consumer care, food, and other industries (including chemical and medical device industries), technologies (cell culture, high-throughput screening, and toxicogenomics), method (cellular assays, biochemical assays, molecular toxicology assays, ex-vivo model, and in silico models.)

The report's scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the in vitro toxicology testing market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the in vitro toxicology testing market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall in vitro toxicology testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (growing public resistance against animal testing, technological advancements, and research and development efforts aimed at early-stage toxicity detection), restraints (resistance of certain regulatory bodies to embrace alternative approaches in toxicology testing, failure to establish intricacies of in vivo conditions, and, lack of in vitro models to study complex endpoints), opportunities (Growing focus on drug discovery and personalized medicine using in vitro methods, Increasing number of toxicology databases, Increasing focus on predictive toxicology), and challenges (lack of data availability and validation, complexity in data analysis and management) influencing the growth of the market.
• Product/Service Development/Innovation: Detailed insights on newly launched products/services of the In vitro toxicology testing market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the In vitro toxicology testing market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), Charles River Laboratories (US), SGS SA (Switzerland), Bio-Rad Laboratories, Inc. (US), Evotec SE (Germany), Promega Corporation (US), Catalent, Inc. (US), Agilent Technologies, Inc. (US), Intertek Group plc (UK), Revvity (US), Inotiv (US), BioIVT (US), Lonza (Switzerland), Creative Biolabs (US), Shanghai Medicilon Inc. (China), Creative Bioarray (US), Aragen Life Sciences Ltd. (India), Enzo Biochem Inc. (US), Microbac Laboratories, Inc. (US), Vimta Labs Ltd. (India), Pacific BioLabs Inc. (US), and MB Research Laboratories (US) and among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
  • 1.2.2 MARKETS COVERED
  • FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET SEGMENTATION
  • 1.2.3 YEARS CONSIDERED
• 1.3 CURRENCY
• 1.4 STAKEHOLDERS
• 1.5 LIMITATIONS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 2 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
  • FIGURE 3 IN VITRO TOXICOLOGY TESTING MARKET: BREAKDOWN OF PRIMARIES
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 4 IN VITRO TOXICOLOGY TESTING: MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
  • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022
  • 2.2.1 INSIGHTS FROM PRIMARIES
  • FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• 2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
  • FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET: CAGR PROJECTIONS
  • FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RISK ANALYSIS
• 2.7 RECESSION IMPACT ANALYSIS
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH)
  • TABLE 2 US: HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
  • TABLE 3 US: HEALTH EXPENDITURE, 2023-2030 (USD MILLION)

3 EXECUTIVE SUMMARY

• FIGURE 12 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
• FIGURE 13 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2023 VS. 2028 (USD MILLION)
• FIGURE 14 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
• FIGURE 15 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2023 VS. 2028 (USD MILLION)
• FIGURE 16 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
• FIGURE 17 GEOGRAPHICAL SNAPSHOT OF IN VITRO TOXICOLOGY TESTING MARKET

4 PREMIUM INSIGHTS

• 4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
  • FIGURE 18 PUBLIC RESISTANCE AGAINST ANIMAL TESTING TO DRIVE MARKET
• 4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD AND COUNTRY (2022)
  • FIGURE 19 CELLULAR ASSAYS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC IN VITRO TOXICOLOGY TESTING MARKET IN 2022
• 4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 20 GERMANY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• 4.4 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY PRODUCT & SERVICE, 2022
  • FIGURE 21 CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 22 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 4 IN VITRO TOXICOLOGY TESTING MARKET: IMPACT ANALYSIS
  • 5.2.1 MARKET DRIVERS
    • 5.2.1.1 Growing public resistance against animal testing
  • FIGURE 23 HISTORY OF EU BAN ON ANIMAL TESTING FOR COSMETICS
    • 5.2.1.2 Technological advancements
    • 5.2.1.3 Research and development efforts aimed at early-stage toxicity detection
  • FIGURE 24 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2014-2028 (USD BILLION)
  • 5.2.2 MARKET RESTRAINTS
    • 5.2.2.1 Resistance of certain regulatory bodies to embrace alternative approaches in toxicology testing
    • 5.2.2.2 Failure to establish intricacies of in vivo conditions
    • 5.2.2.3 Lack of in vitro models to study complex endpoints
  • 5.2.3 MARKET OPPORTUNITIES
    • 5.2.3.1 Growing focus on drug discovery and personalized medicine using in vitro methods
    • 5.2.3.2 Increasing number of toxicology databases
  • TABLE 5 CHEMICAL TOXICITY DATABASES
    • 5.2.3.3 Increasing focus on predictive toxicology
  • 5.2.4 MARKET CHALLENGES
    • 5.2.4.1 Lack of data availability and validation
    • 5.2.4.2 Complexity in data analysis and management
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 25 REVENUE SHIFT & NEW POCKETS FOR IN VITRO TOXICOLOGY TESTING PRODUCT/SERVICE PROVIDERS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2022
  • TABLE 6 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY KEY PLAYER
  • 5.4.2 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY REGION, 2022
  • TABLE 7 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY REGION
  • 5.4.3 AVERAGE SELLING PRICE TREND
• 5.5 VALUE CHAIN ANALYSIS
  • FIGURE 26 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING PRODUCT DEVELOPMENT AND MANUFACTURING PHASE
• 5.6 SUPPLY CHAIN ANALYSIS
  • FIGURE 27 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
• 5.7 ECOSYSTEM ANALYSIS
  • FIGURE 28 ECOSYSTEM ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
  • TABLE 8 ECOSYSTEM FOR IN VITRO TOXICOLOGY TESTING MARKET
• 5.8 PATENT ANALYSIS
  • FIGURE 29 IN VITRO TOXICOLOGY TESTING MARKET: PATENTS GRANTED (JANUARY 2013-SEPTEMBER 2023)
• 5.9 TECHNOLOGY ANALYSIS
• 5.10 KEY CONFERENCES & EVENTS, 2023-2024
  • TABLE 9 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
• 5.11 REGULATORY LANDSCAPE
  • 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11.2 REGULATORY SCENARIO
  • TABLE 14 IN VITRO TOXICOLOGY TESTING MARKET: REGULATORY SCENARIO
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 15 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF IN VITRO TOXICOLOGY TESTING
  • 5.13.2 BUYING CRITERIA FOR IN VITRO TOXICITY TESTING
  • FIGURE 31 KEY BUYING CRITERIA FOR END USERS

6 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE

• 6.1 INTRODUCTION
  • TABLE 16 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
• 6.2 CONSUMABLES
  • 6.2.1 INCREASING DEMAND FOR HIGH-QUALITY REAGENTS TO DRIVE MARKET
  • TABLE 17 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 18 EUROPE: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 19 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 20 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 21 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 22 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.3 ASSAYS
  • TABLE 23 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 24 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 25 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 28 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 29 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.1 BACTERIAL TOXICITY ASSAYS
    • 6.3.1.1 High sample throughput and rapid response to toxicants to drive adoption
  • TABLE 30 BACTERIAL TOXICITY ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 31 EUROPE: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 33 ASIA PACIFIC: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 34 LATIN AMERICA: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 35 MIDDLE EAST & AFRICA: BACTERIAL TOXICITY ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.2 ENZYME TOXICITY ASSAYS
    • 6.3.2.1 Increasingly used in endocrine-disrupting studies
  • TABLE 36 ENZYME TOXICITY ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 37 EUROPE: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 40 LATIN AMERICA: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 41 MIDDLE EAST & AFRICA: ENZYME TOXICITY ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.3 CELL-BASED ELISA & WESTERN BLOTTING ASSAYS
    • 6.3.3.1 Simple, fast, and cost-effective alternatives to large-scale and cost-intensive animal testing
  • TABLE 42 CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 43 EUROPE: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 44 NORTH AMERICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 46 LATIN AMERICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 47 MIDDLE EAST & AFRICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.4 RECEPTOR-BINDING ASSAYS
    • 6.3.4.1 Suitable for high-throughput formats
  • TABLE 48 RECEPTOR-BINDING ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 49 EUROPE: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 50 NORTH AMERICA: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 52 LATIN AMERICA: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 53 MIDDLE EAST & AFRICA: RECEPTOR-BINDING ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.5 TISSUE CULTURE ASSAYS
    • 6.3.5.1 Increasing cost of animal studies to propel market
  • TABLE 54 TISSUE CULTURE ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 55 EUROPE: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 56 NORTH AMERICA: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 58 LATIN AMERICA: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 59 MIDDLE EAST & AFRICA: TISSUE CULTURE ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.6 OTHER ASSAYS
  • TABLE 60 OTHER ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 61 EUROPE: OTHER ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 62 NORTH AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: OTHER ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 64 LATIN AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 65 MIDDLE EAST & AFRICA: OTHER ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.4 SERVICES
  • 6.4.1 LACK OF INFRASTRUCTURE AND EXPERTISE IN RESEARCH CENTERS TO SUPPORT MARKET GROWTH
  • TABLE 66 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 67 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 68 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 70 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 71 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.5 EQUIPMENT
  • 6.5.1 ADOPTION OF ADVANCED TESTING EQUIPMENT TO MEET NEW REGULATORY STANDARDS TO PROPEL MARKET
  • TABLE 72 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 73 EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 74 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 76 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 77 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.6 SOFTWARE
  • 6.6.1 CRUCIAL ROLE IN DECREASING ANALYSIS TIME AND EFFECTIVELY HANDLING SUBSTANTIAL DATA VOLUMES
  • TABLE 78 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 80 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 82 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 83 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY REGION, 2021-2028 (USD MILLION)

7 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST

• 7.1 INTRODUCTION
  • TABLE 84 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2021-2028 (USD MILLION)
• 7.2 ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION
  • 7.2.1 PRODUCES HIGHLY REPRODUCIBLE & ACCURATE DATA
  • TABLE 85 IN VITRO ADME TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 86 EUROPE: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 87 NORTH AMERICA: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 89 LATIN AMERICA: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 90 MIDDLE EAST & AFRICA: IN VITRO ADME TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.3 GENOTOXICITY
  • 7.3.1 RIGOROUS REGULATORY REQUIREMENTS FOR NEW DRUGS TO AID MARKET GROWTH
  • TABLE 91 IN VITRO GENOTOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 92 EUROPE: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 93 NORTH AMERICA: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 95 LATIN AMERICA: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 96 MIDDLE EAST & AFRICA: IN VITRO GENOTOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.4 SKIN IRRITATION, CORROSION, & SENSITIZATION
  • 7.4.1 MAJOR ENDPOINTS STUDIED IN COSMETICS INDUSTRY
  • TABLE 97 IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 98 EUROPE: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 101 LATIN AMERICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.5 CYTOTOXICITY
  • 7.5.1 RISING NEED FOR BIOSAFETY TO SUPPORT MARKET GROWTH
  • TABLE 103 IN VITRO CYTOTOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 104 EUROPE: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 105 NORTH AMERICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 107 LATIN AMERICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.6 OCULAR TOXICITY
  • 7.6.1 IN VITRO AND EX VIVO TECHNIQUES INCREASINGLY GAINING ATTENTION FOR EVALUATION OF OCULAR TOXICITY
  • TABLE 109 IN VITRO OCULAR TOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 110 EUROPE: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 111 NORTH AMERICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 113 LATIN AMERICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 114 MIDDLE EAST & AFRICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.7 ORGAN TOXICITY
  • 7.7.1 FASTEST-GROWING SEGMENT OF MARKET
  • TABLE 115 IN VITRO ORGAN TOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 116 EUROPE: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 117 NORTH AMERICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 119 LATIN AMERICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 120 MIDDLE EAST & AFRICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.8 DERMAL TOXICITY
  • 7.8.1 ONGOING GOVERNMENT INITIATIVES AND CHANGES IN REGULATORY GUIDELINES TO SUPPORT MARKET GROWTH
  • TABLE 121 IN VITRO DERMAL TOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 122 EUROPE: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 123 NORTH AMERICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 125 LATIN AMERICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 126 MIDDLE EAST & AFRICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.9 PHOTOTOXICITY
  • 7.9.1 ESTABLISHED NON-ANIMAL TECHNIQUES EMPLOYED TO ASSESS PHOTOTOXICITY OF COSMETICS, PHARMACEUTICALS, AND CHEMICALS
  • TABLE 127 IN VITRO PHOTOTOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 128 EUROPE: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 129 NORTH AMERICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 131 LATIN AMERICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.10 OTHER ENDPOINTS & TESTS
  • TABLE 133 OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 134 EUROPE: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 135 NORTH AMERICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 137 LATIN AMERICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 138 MIDDLE EAST & AFRICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)

8 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY

• 8.1 INTRODUCTION
  • TABLE 139 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
• 8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL
  • 8.2.1 GROWING R&D EXPENDITURE TO FAVOR MARKET GROWTH
  • TABLE 140 IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 141 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 142 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 144 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 145 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
• 8.3 CONSUMER CARE
  • 8.3.1 GROWING DEMAND FOR CRUELTY-FREE COSMETICS AND PERSONAL CARE PRODUCTS TO DRIVE MARKET
  • TABLE 146 IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 147 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 148 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 150 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
• 8.4 FOOD
  • 8.4.1 INCREASING FOCUS ON FOOD SAFETY TO PROPEL MARKET
  • TABLE 152 TYPES OF TOXICOLOGY TESTS FOR FOOD
  • TABLE 153 IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 154 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 155 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 157 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 158 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
• 8.5 OTHER INDUSTRIES
  • TABLE 159 IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 160 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 161 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 163 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY REGION, 2021-2028 (USD MILLION)

9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

• 9.1 INTRODUCTION
  • TABLE 165 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
• 9.2 CELL CULTURE
  • 9.2.1 MOST PREFERRED TECHNIQUE FOR TOXICITY TESTING
  • TABLE 166 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 167 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 168 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 170 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY REGION, 2021-2028 (USD MILLION)
• 9.3 HIGH-THROUGHPUT SCREENING
  • 9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IN TOXICITY TESTING TO BOOST MARKET GROWTH
  • TABLE 172 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 173 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 174 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 176 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2021-2028 (USD MILLION)
• 9.4 TOXICOGENOMICS
  • 9.4.1 TECHNOLOGICAL ADVANCEMENTS IN PROTEOMICS AND GENOMICS TO DRIVE MARKET
  • TABLE 178 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 179 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 180 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 182 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY REGION, 2021-2028 (USD MILLION)

10 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD

• 10.1 INTRODUCTION
  • TABLE 184 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
• 10.2 CELLULAR ASSAYS
  • 10.2.1 DEVELOPMENT OF MULTIPARAMETER ASSAYS TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET PLAYERS
  • TABLE 185 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 186 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 187 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 189 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 190 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY REGION, 2021-2028 (USD MILLION)
• 10.3 BIOCHEMICAL ASSAYS
  • 10.3.1 HELP REFLECT UPON UNNATURAL CHANGES INDUCED BY TEST SUBSTANCES
  • TABLE 191 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 192 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 193 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 194 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 195 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 196 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY REGION, 2021-2028 (USD MILLION)
• 10.4 MOLECULAR TOXICOLOGY ASSAYS
  • 10.4.1 RISING INVESTMENTS IN MOLECULAR TOXICOLOGY TECHNOLOGIES TO DRIVE MARKET
  • TABLE 197 IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 198 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 199 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 200 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 201 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY REGION, 2021-2028 (USD MILLION)
• 10.5 EX VIVO MODELS
  • 10.5.1 RISING DEMAND FOR ALTERNATIVES TO ANIMAL TESTING TO DRIVE MARKET
  • TABLE 203 IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 204 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 205 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 206 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 207 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY REGION, 2021-2028 (USD MILLION)
• 10.6 IN SILICO MODELS
  • 10.6.1 HELP REDUCE NUMBER OF SAMPLES TESTED
  • TABLE 209 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 210 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 211 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 213 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY REGION, 2021-2028 (USD MILLION)

11 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION

• 11.1 INTRODUCTION
  • TABLE 215 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 11.2 EUROPE
  • FIGURE 32 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • TABLE 216 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 217 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 218 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 219 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 220 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 221 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 222 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.2.1 GERMANY
    • 11.2.1.1 Well-established pharmaceuticals industry to support market growth
  • TABLE 223 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 224 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 225 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 226 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 227 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 228 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.2.2 UK
    • 11.2.2.1 Rising focus on research activities and academia-industry partnerships to drive market
  • TABLE 229 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 230 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 231 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 232 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 233 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 234 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.2.3 FRANCE
    • 11.2.3.1 Increasing government funding for proteomics and genomics research to drive market
  • TABLE 235 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 236 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 237 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 238 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 239 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 240 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.2.4 ITALY
    • 11.2.4.1 Increasing life sciences research to propel market
  • TABLE 241 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 242 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 243 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 244 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 245 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 246 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.2.5 SPAIN
    • 11.2.5.1 Growing chemicals industry to support market growth
  • TABLE 247 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 248 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 249 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 250 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 251 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 252 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.2.6 REST OF EUROPE
  • TABLE 253 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 254 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 255 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 256 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 257 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 258 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.2.7 RECESSION IMPACT
• 11.3 NORTH AMERICA
  • TABLE 259 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 260 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 261 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 262 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 263 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 264 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 265 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.3.1 US
    • 11.3.1.1 Growing focus on biomarker discovery and research in structure-based drug design to propel market
  • TABLE 266 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 267 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 268 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 269 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 270 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 271 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.3.2 CANADA
    • 11.3.2.1 Strong support to carry out R&D in pharmaceutical and proteomics fields to boost market growth
  • TABLE 272 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 273 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 274 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 275 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 276 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 277 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.3.3 RECESSION IMPACT
• 11.4 ASIA PACIFIC
  • FIGURE 33 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • TABLE 278 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 279 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 280 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 281 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 283 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 284 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.4.1 CHINA
    • 11.4.1.1 Increasing international pressure to ban animal testing methods to propel market
  • TABLE 285 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 286 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 287 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 288 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 289 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 290 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.4.2 JAPAN
    • 11.4.2.1 Rising demand for technologically advanced research products to drive market
  • TABLE 291 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 292 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 293 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 294 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 295 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 296 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.4.3 INDIA
    • 11.4.3.1 Growing focus of universities on avoiding use of animals to test cosmetic products to propel market
  • TABLE 297 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 298 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 299 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 300 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 301 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 302 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.4.4 SOUTH KOREA
    • 11.4.4.1 Growing focus of government to increase pharmaceutical spending to propel market growth
  • TABLE 303 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 304 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 305 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 306 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 307 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 308 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.4.5 REST OF ASIA PACIFIC
  • TABLE 309 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 310 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 311 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 312 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 313 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 314 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.4.6 RECESSION IMPACT
• 11.5 LATIN AMERICA
  • TABLE 315 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 316 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 317 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 318 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 319 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 320 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 321 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.5.1 BRAZIL
    • 11.5.1.1 Adoption of non-animal testing methods to propel market
  • TABLE 322 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 323 BRAZIL: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 324 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 325 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 326 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 327 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.5.2 MEXICO
    • 11.5.2.1 Ban on animal testing for cosmetics to support market growth
  • TABLE 328 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 329 MEXICO: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 330 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 331 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 332 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 333 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.5.3 REST OF LATIN AMERICA
  • TABLE 334 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 335 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 336 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 337 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 338 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 339 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.5.4 RECESSION IMPACT
• 11.6 MIDDLE EAST & AFRICA
  • TABLE 340 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 341 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 342 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 343 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 344 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 345 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 346 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.6.1 MIDDLE EAST
    • 11.6.1.1 Growing focus on AI-based technologies for drug discovery to drive market
  • TABLE 347 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 348 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 349 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 350 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 351 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 352 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.6.2 AFRICA
    • 11.6.2.1 Precision medicine initiatives to fuel market growth
  • TABLE 353 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 354 AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 355 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021-2028 (USD MILLION)
  • TABLE 356 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 357 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2028 (USD MILLION)
  • TABLE 358 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • 11.6.3 RECESSION IMPACT

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • FIGURE 34 IN VITRO TOXICOLOGY TESTING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
• 12.3 REVENUE SHARE ANALYSIS
  • FIGURE 35 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET, 2018-2022
• 12.4 MARKET SHARE ANALYSIS
  • FIGURE 36 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 359 IN VITRO TOXICOLOGY TESTING MARKET: DEGREE OF COMPETITION
• 12.5 COMPANY EVALUATION MATRIX
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • FIGURE 37 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • 12.5.5 COMPANY FOOTPRINT
  • TABLE 360 OVERALL FOOTPRINT ANALYSIS OF COMPANIES (2022)
    • 12.5.5.1 Product/Service footprint analysis
  • TABLE 361 PRODUCT/SERVICE FOOTPRINT ANALYSIS OF COMPANIES (2022)
    • 12.5.5.2 Regional footprint analysis
  • TABLE 362 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES (2022)
• 12.6 STARTUP/SME EVALUATION MATRIX
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 STARTING BLOCKS
  • 12.6.3 RESPONSIVE COMPANIES
  • 12.6.4 DYNAMIC COMPANIES
  • FIGURE 38 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
  • 12.6.5 COMPETITIVE BENCHMARKING
  • TABLE 363 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 364 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
• 12.7 COMPETITIVE SCENARIO
  • TABLE 365 KEY PRODUCT/SERVICE LAUNCHES
  • TABLE 366 KEY DEALS
  • TABLE 367 OTHER KEY DEVELOPMENTS

13 COMPANY PROFILES

• (Business Overview, Products & Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 13.1 MAJOR PLAYERS
  • 13.1.1 THERMO FISHER SCIENTIFIC INC.
  • TABLE 368 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
  • FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  • 13.1.2 AGILENT TECHNOLOGIES, INC.
  • TABLE 369 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
  • FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
  • 13.1.3 MERCK KGAA
  • TABLE 370 MERCK KGAA: BUSINESS OVERVIEW
  • FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
  • 13.1.4 LABORATORY CORPORATION OF AMERICA HOLDINGS
  • TABLE 371 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
  • FIGURE 42 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022)
  • 13.1.5 EUROFINS SCIENTIFIC
  • TABLE 372 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
  • FIGURE 43 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
  • 13.1.6 CHARLES RIVER LABORATORIES
  • TABLE 373 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
  • FIGURE 44 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
  • 13.1.7 SGS SA
  • TABLE 374 SGS SA: BUSINESS OVERVIEW
  • FIGURE 45 SGS SA: COMPANY SNAPSHOT (2022)
  • 13.1.8 REVVITY
  • TABLE 375 REVVITY: BUSINESS OVERVIEW
  • FIGURE 46 REVVITY: COMPANY SNAPSHOT (2022)
  • 13.1.9 BIO-RAD LABORATORIES, INC.
  • TABLE 376 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
  • FIGURE 47 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
  • 13.1.10 LONZA
  • TABLE 377 LONZA: BUSINESS OVERVIEW
  • FIGURE 48 LONZA: COMPANY SNAPSHOT (2022)
  • 13.1.11 EVOTEC SE
  • TABLE 378 EVOTEC SE: BUSINESS OVERVIEW
  • FIGURE 49 EVOTEC SE: COMPANY SNAPSHOT (2022)
  • 13.1.12 CATALENT, INC.
  • TABLE 379 CATALENT, INC.: BUSINESS OVERVIEW
  • FIGURE 50 CATALENT, INC.: COMPANY SNAPSHOT (2022)
  • 13.1.13 INTERTEK GROUP PLC
  • TABLE 380 INTERTEK GROUP PLC: BUSINESS OVERVIEW
  • FIGURE 51 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2022)
  • 13.1.14 INOTIV
  • TABLE 381 INOTIV: BUSINESS OVERVIEW
  • FIGURE 52 INOTIV: COMPANY SNAPSHOT (2022)
  • 13.1.15 PROMEGA CORPORATION
  • TABLE 382 PROMEGA CORPORATION: BUSINESS OVERVIEW
• 13.2 OTHER PLAYERS
  • 13.2.1 BIOIVT
  • TABLE 383 BIOIVT: COMPANY OVERVIEW
  • 13.2.2 CREATIVE BIOLABS
  • TABLE 384 CREATIVE BIOLABS: COMPANY OVERVIEW
  • 13.2.3 SHANGHAI MEDICILON INC.
  • TABLE 385 SHANGHAI MEDICILON INC.: COMPANY OVERVIEW
  • 13.2.4 CREATIVE BIOARRAY
  • TABLE 386 CREATIVE BIOARRAY: COMPANY OVERVIEW
  • 13.2.5 ARAGEN LIFE SCIENCES LTD.
  • TABLE 387 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
  • 13.2.6 ENZO BIOCHEM INC.
  • TABLE 388 ENZO BIOCHEM INC.: COMPANY OVERVIEW
  • 13.2.7 MICROBAC LABORATORIES, INC.
  • TABLE 389 MICROBAC LABORATORIES, INC.: COMPANY OVERVIEW
  • 13.2.8 VIMTA LABS LTD.
  • TABLE 390 VIMTA LABS LTD.: COMPANY OVERVIEW
  • 13.2.9 PACIFIC BIOLABS, INC.
  • TABLE 391 PACIFIC BIOLABS, INC.: COMPANY OVERVIEW
  • 13.2.10 MB RESEARCH LABORATORIES
  • TABLE 392 MB RESEARCH LABORATORIES: COMPANY OVERVIEW
• *Details on Business Overview, Products & Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

관련자료